Read articleListen Press Release New Mayo Clinic Studies Demonstrate MyPhenome Test Predicts Weight Loss Outcomes Across Treatments, Including GLP-1s and Surgical Interventions PR Newswire - Menlo Park Calif
Incorporate: Aerobic exercise, such as brisk walking, jogging or swimming, three to five times per week Resistance training, such as weightlifting and bodyweight exercises, two to three times a week Prioritize sleep
Clinical Response At both Weeks 16 and 52, a greater proportion of patients treated with TALTZ 80 mg Q4W had ASAS40 response compared to patients treated with placebo (Table 10)
This approval was based on the SELECT trial, which demonstrated significant cardiovascular risk reduction in this population
Clinical evidence suggests that combining both agents may produce additive benefits for weight loss and A1C reduction in patients with type 2 diabetes or metabolic syndrome